ARCHIVES

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011

Hormone Therapy At Menopause Linked to More Breast Cancer Risk

February 25, 2011

Frederick Center Should Have Top Scientist As Director, 20% Of Budget or Basic Research

December 21, 1973

In Brief: Holland Recovering From Coronary Bypass; Henry Kaplan Receives Annual Prentis Award

July 25, 1980

Foundations Invites Antitobacco Proposals

October 15, 1993

AACR Completes List Of Symposia Chairpersons

April 22, 1988